Professur für Translationale Immunforschung bei chronisch entzündlichen Darmerkrankungen

Spatial Single Cell Profiling Using Imaging Mass Cytometry: Inflammatory Versus Penetrating Crohn's Disease (2024) Lehmann M, Weixler B, Elezkurtaj S, Loddenkemper C, Atreya I, Atreya R, Bacher P, et al. Journal article Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) (Version 4.1) – living guideline (2024) Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignass A, Ehehalt R, Germer CT, et al. Journal article PragmaticTrial Design to Compare Real-world Effectiveness of DifferentTreatments for Inflammatory Bowel Diseases:The PRACTICE-IBD European Consensus (2024) Fantini MC, Fiorino G, Colli A, Laharie D, Armuzzi A, Caprioli FA, Gisbert JP, et al. Journal article Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease (2024) Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D’Haens G, Ferrante M, Schreiber S, et al. Journal article Burden of Bowel Urgency in Patients with Ulcerative Colitis and Crohn's Disease: A Real-World Global Study (2024) Atreya R, Redondo I, Streit P, Protic M, Hartz S, Gurses G, Knight H, et al. Journal article Blocking GPR15 Counteracts Integrin-dependent T Cell Gut Homing in Vivo (2024) Schramm S, Liu L, Saad M, Dietz L, Dedden M, Müller T, Atreya I, et al. Journal article Glowing insights: tracking vedolizumab in the mucosa of patients with IBD via molecular endoscopy (2024) Atreya R Journal article Aktualisierte S3-Leitlinie Colitis ulcerosa (Version 6.2) (2024) Kucharzik T, Dignass A, Atreya R, Bokemeyer B, Esters P, Herrlinger K, Kannengiesser K, et al. Journal article Unklarer Bauch: Eine therapeutische Herausforderung (2024) Atreya R Journal article Etrolizumab-s fails to control E-Cadherin-dependent co-stimulation of highly activated cytotoxic T cells (2024) Wiendl M, Dedden M, Liu L, Schweda A, Paap EM, Ullrich K, Hartmann L, et al. Journal article